Juvenile hyaline fibromatosis
(Redirected from Fibromatosis hyalinica multiplex juvenilis)
Juvenile hyaline fibromatosis (JHF) is a rare genetic disorder characterized by the abnormal growth of fibrous tissue in the skin, joints, and other parts of the body. This condition typically presents in early childhood and can lead to significant physical deformities and functional impairments.
Presentation[edit | edit source]
JHF usually manifests within the first few years of life. Common symptoms include:
- Skin lesions: These are firm, painless nodules that can appear on the scalp, face, neck, and other areas.
- Joint contractures: Stiffness and limited range of motion in the joints, often leading to deformities.
- Gingival hypertrophy: Overgrowth of the gum tissue.
- Bone lesions: These can lead to bone pain and fractures.
Genetics[edit | edit source]
Juvenile hyaline fibromatosis is inherited in an autosomal recessive pattern. Mutations in the ANTXR2 gene, also known as the CMG2 gene, are responsible for this disorder. The ANTXR2 gene provides instructions for making a protein that is involved in the formation of the extracellular matrix, which provides structural support to tissues.
Diagnosis[edit | edit source]
Diagnosis of JHF is based on clinical evaluation, family history, and the identification of characteristic symptoms. Genetic testing can confirm the diagnosis by detecting mutations in the ANTXR2 gene. Biopsy of the skin lesions may show the presence of hyaline material in the dermis.
Treatment[edit | edit source]
There is no cure for JHF, and treatment is primarily supportive and symptomatic. Management strategies include:
- Physical therapy: To maintain joint mobility and prevent contractures.
- Surgical intervention: To remove large skin lesions or correct severe joint deformities.
- Pain management: Using medications to alleviate discomfort.
Prognosis[edit | edit source]
The prognosis for individuals with JHF varies. Some may experience a relatively mild course, while others may develop severe complications that significantly impact their quality of life. Early diagnosis and intervention can help manage symptoms and improve outcomes.
See also[edit | edit source]
References[edit | edit source]
External links[edit | edit source]
-
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD